Skip to content
Screener

Scholar Rock SRRK Asset turnover

Asset turnover at other companies

Biogen logo
BiogenBIIB
0.3×0.0×
PTC Therapeutics logo
PTC TherapeuticsPTCT
0.3×-0.5×
CalAmp logo
CalAmpCAMP
0×—
Wave Life Sciences logo
Wave Life SciencesWVE
0.5×+0.3×

Other financials

Income statement

See full
Revenue-—
Operating income-$108.9M+2.9%
Net income-$109.9M+0.1%
EPS (diluted)-$0.84+14.3%

Balance sheet

See full
Cash & equivalents$437.1M+186%
Total debt$203.8M+231%
Total equity$253.8M+8.8%
Total assets$523.5M+54.0%

Cash flow

See full
Operating cash flow-$70.3M+8.6%
CapEx$1.0K-99.5%
Free cash flow-$70.3M+8.9%

Valuation

See full
Market cap$5.74B+72.4%
Enterprise value$5.5B+70.1%

Profitability

See full
Operating margin-231.8%—
Net margin-236.9%—
FCF margin-309.1%—

Returns & leverage

See full
Return on equity-167.8%-4.1pp
Debt / equity0.8×+0.5×
Current ratio7×+0.7×

Where this comes from

Calculated from Scholar Rock’s reported figures.

total revenue/total assets=0×

Based on trailing twelve months.

The source filing: Scholar Rock’s 10-Q, filed August 6, 2026. Open the filing →

Filed
Aug 6, 2026, 7:20 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-336732

FAQ

What is Scholar Rock's asset turnover?
Scholar Rock (SRRK) reported asset turnover of 0× in Q2 2026.
What does asset turnover mean?
Trailing-twelve-month revenue divided by average total assets. Measures how many dollars of sales each dollar of assets generates — the efficiency leg of the DuPont decomposition of ROE.

Ask your AI about Scholar Rock's asset turnover.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude